We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Rua Life Sciences Plc | LSE:RUA | London | Ordinary Share | GB0033360586 | ORD 5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 12.00 | 11.50 | 12.50 | 12.00 | 12.00 | 12.00 | 183,413 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Plastics,resins,elastomers | 2.19M | -1.44M | -0.0232 | -5.17 | 7.45M |
TIDMRUA
RNS Number : 3141W
London Stock Exchange Notice
11 December 2023
Hot Features
Premium
Market Notice
11 December 2023
N05/23 - RUA Life Sciences PLC - Suspension of trading and settlement
situation
1. London Stock Exchange ("the Exchange") has been monitoring the settlement situation in RUA Life Sciences PLC (ISIN: GB0033360586 ) following the Company's recent notification in relation to the issue of new shares which are conditional on shareholder consent. As a result of the deterioration in settlement performance, the trading of RUA Life Sciences PLC shares has been temporarily suspended under Rule 1510 of the Rules of the London Stock Exchange. Settlement of outstanding transactions can continue whilst the security is suspended. The Exchange will continue to monitor the settlement situation and when trading is to be restored, the market will be notified by Stock Exchange Notice.
2. Rule 5000 (Obligation to settle) and its associated guidance places an obligation on member firms to ensure that every on Exchange trade is duly settled on the agreed settlement date. This obligation remains even if the reason for non-settlement is a customer or counterparty having failed to settle other transactions in the same security.
3. Any queries on this Notice should be addressed to Market Supervision, Market Regulation, telephone +44 (0)20 7797 3666 (STX 33666) option 2.
Liam Smith
Head of Market Supervision
This Stock Exchange Notice will be available on the website at https://www.londonstockexchange.com/resources/london-stock-exchange-notices
Calls to the London Stock Exchange plc may be recorded to enable the London Stock Exchange to carry out its regulatory responsibilities.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
SENFIFVDFSLLLIV
(END) Dow Jones Newswires
December 11, 2023 02:37 ET (07:37 GMT)
1 Year Rua Life Sciences Chart |
1 Month Rua Life Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
